期刊文献+

VEGF对良恶性心包积液的鉴别诊断价值 被引量:1

The value of VEGF in the diagnosis of pericardial effusion
下载PDF
导出
摘要 目的探讨VEGF在心包积液病因鉴别诊断中的临床应用价值。方法采用ELISA法,检测34例恶性心包积液与25例非恶性心包积液中VEGF水平,比较良、恶性心包积液中VEGF水平差异。结果恶性心包积液中VEGF水平明显高于非恶性心包积液,当VEGF>1908pg/ml,对恶性心包积液的诊断敏感性及特异性为88%和83.3%。结论恶性心包积液中VEGF水平明显增高,VEGF可作为良恶性心包积液的鉴别诊断的标志物。 Objective To explore the clinical value of VEGF in the differential diagnosis of pericardial effusion.Methods Using an enzyme-linked immunosorbent assay,we assessed pericardial VEGF levels in patients with malignant pericardial effusion(n=34),in patients with nonmalignant pericardial effusion(n=25).Results VEGF pericardial levels in malignant pericardial effusion were significantly higher compared with VEGF in nonmalignant effusion.Pericardial VEGF levels≥1 908pg/ml had88% sensitivity and 83.3%specificity for the recognition of malignant pericardial effusion in patients with malignant pericardial effusion.Conclusion VEGF levels were significantly higher in malignant pericardial effusion.VEGF in pericardial effusion offers potential as a diagnostic tool to discriminate malignant from benign effusions.
出处 《滨州医学院学报》 2015年第5期338-339,342,共3页 Journal of Binzhou Medical University
关键词 心包积液 血管内皮生长因子 诊断 pericardial effusion, VEGF, diagnosis
  • 相关文献

参考文献10

二级参考文献31

  • 1韩立宪,陈树平,元柏民,杨建国,李红稳,高宏,王希耕.60例心包积液行纤维心包镜检查的病因探讨[J].中华心血管病杂志,1996,24(2):138-138. 被引量:18
  • 2Jimenez D,Diaz G,Peroz E,et al.Diagnostic value of adenosine deaminase in nontuberulous lymphocytin pleural effusions[J].Eur Respire J,2003,21(2):220-224.
  • 3Neufeld G,Cohen T,Cengrinovitch S,et al.vascular endothelial growth factor (VEGF) and its receptors[J].FASEB J,1999,13(1):9-22.
  • 4Oyama T,Ran S,Ishida T,et al.Vascular endothelial growth factor affects dendritic cell maturation through the inhibtion of nuclear factor-KB activation in the mopoietic progenitor cells[J].J Immunol,1998,160(8):1224-1230.
  • 5李基业.腺苷酸脱氨酶测定对恶性腹腔积液的鉴别诊断价值.中华结核和呼吸杂志,1989,.
  • 6杨兴生 黄大显.234例成人尸检病例心包积液病因分析[J].中华内科杂志,1983,22(6):138-140.
  • 7Parki DM, Bray FI, Devesa SS. Cancer burden in the year 2000. The global Picture[J]. Eur J Caneer,2001,37 :54.
  • 8Crew KD, Neugut A1. Epidemiology of gastric cancer[J]. World J Gastroenterol,2006,12:354.
  • 9Ciardiello F, Tortora G. EGFR antagonists in cancer treat- ment[J]. N Engl J Med,2008,358( 11 ) :1160.
  • 10Molinari F, Martin V, Saletti P, et al. Differing deregulation of EGFR and downstream proteins in primary colorectal cancer and related metastatic sites may be clinically relevant[J]. Br J Cancer,2009,100(7) : 1087.

共引文献52

同被引文献24

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部